Serum Institute of India stopped Covishield production in December 2021: Adar Poonawalla
PUNE: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the...
Serum Institute of India
India recommends nod to SII for phase 2/3 trials of Covid-19 vaccine Covovaxon children
NEW DELHI: An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India...
Serum Institute has to ‘catch up’, supply Covid-19 vaccines: WHO chief
NEW YORK: WHO chief Tedros Adhanom Ghebreyesus has said that once the devastating COVID-19 outbreak in India recedes, the Serum...
Will return to India in a few days, says Adar Poonawalla
MUMBAI: Serum Institute of India (SII) CEO Adar Poonawalla has said he will return to India from London in a...
Covisheld is the most affordable Covid-19 vaccine available: Serum Institute defends vaccine pricing
NEW DELHI: Serum Institute of India (SII), which makes the most used Covid-19 vaccine in the country, on Saturday defended...
Modi government approves Rs 4,500 crore credit to Covid-19 vaccine makers Serum Institute of India, Bharat Biotech to ramp up production
NEW DELHI: Looking to ramp up supplies ahead of the opening of Covid-19 vaccination to all citizens over 18 years...
Oxford-AstraZeneca Covid-19 vaccine: WHO rejects Serum Institute of India’s proposal for extension of Covishield’s shelf life
NEW DELHI: The WHO has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19...
Serum Institute of India require around Rs 3,000 crore to ramp up vaccine production: Adar Poonawalla
NEW DELHI: Serum Institute of India (SII) would require around Rs 3,000 crore to ramp up production capacity for making...
